Multiple sclerosis in 2021: progress against progression
Lancet Neurol
.
2022 Jan;21(1):12-13.
doi: 10.1016/S1474-4422(21)00417-8.
Authors
Erin S Beck
1
,
Daniel S Reich
2
Affiliations
1
Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: erin.beck@mssm.edu.
2
National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
PMID:
34942123
DOI:
10.1016/S1474-4422(21)00417-8
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Disease Progression
Humans
Multiple Sclerosis* / therapy
Multiple Sclerosis, Chronic Progressive*